• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MOLNYCKE HEALTH CARE MEPILEX BORDER POST OP AG; WOUND DRESSING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MOLNYCKE HEALTH CARE MEPILEX BORDER POST OP AG; WOUND DRESSING Back to Search Results
Model Number 498650
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Erythema (1840); Skin Irritation (2076); Swelling (2091); Post Operative Wound Infection (2446)
Date of Event 09/21/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The warnings and precautions section of the instructions for use (ifu) states mepilex ag is intended for short-term use up to 4 weeks.For long-term use, a clinical assessment by a physician is recommended.A similar size product available in the us was selected for fda submission.
 
Event or Problem Description
A nurse reported a patient may have developed a sensitivity to mepilex ag dressing.Bilateral amputee continually using mepilex ag since (b)(6).Wound developed staph, redness (erythema) and swelling.Use of mepilex ag has been discontinued and iv antibiotics administered.The nurse stated there is no issue with the product, but it has been in use for too long.Request was made for additional information.Additional information received (b)(6) 2018 indicated mepilex ag dressings were in use on arms and legs on superficial skin breakdowns post amputation of 4 limbs below elbow and below knee.Patient was readmitted (b)(6) 2018 for sepsis unknown site.Wounds were cleansed with normal saline, with 2x week dressing changes.Reaction reported of redness (erythema), skin irritation, blisters and infection, 30cmx20cm size, under the area where the dressing was placed.Use of mepilex ag dressing was discontinued.Antiseptic wash, betadine gauze to all areas, then daily sorbact dressing.Wound is healing well with iv antibiotics.Surgeon has requested use of mepilex ag dressing to resume.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MEPILEX BORDER POST OP AG
Common Device Name
WOUND DRESSING
Manufacturer (Section D)
MOLNYCKE HEALTH CARE
5550 peachtree parkway
suite 500
norcross GA 30092
MDR Report Key7987522
Report Number3004763499-2018-00005
Device Sequence Number18128923
Product Code FRO
Combination Product (Y/N)N
PMA/510(K) Number
K100029
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Nurse
Type of Report Initial
Report Date (Section B) 09/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number498650
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/21/2018
Initial Report FDA Received Date10/19/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age55 YR
-
-